KOCAA
RVMD icon

Knights of Columbus Asset Advisors’s Revolution Medicines RVMD Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,114
Closed -$965K – 419
2025
Q4 		$965K Sell
12,114
-459
-4% -$30.1K 0.05% 265
2025
Q3 		$587K Buy
+12,573
New +$492K 0.03% 286

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Knights of Columbus Asset Advisors's RVMD Position: Q1 2026 in Review

Knights of Columbus Asset Advisors sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 12,114 shares — an estimated $965K sold.

Knights of Columbus Asset Advisors first reported a position in RVMD in Q3 2025 and held it in 2 quarters. The position peaked at $965K in Q4 2025. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Knights of Columbus Asset Advisors reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 12,114 Revolution Medicines shares in Q1 2026, an estimated $965K.
  • Knights of Columbus Asset Advisors first reported a position in Revolution Medicines in Q3 2025 and held it in 2 quarters.
  • Knights of Columbus Asset Advisors's Revolution Medicines position peaked at $965K in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q1 2026, filed 11 May 2026.